Experimental Physiology
	

Celebrating 100 years
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Experimental Physiology 93.5 pp 599-612
DOI: 10.1113/expphysiol.2007.041830
© The Physiological Society 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
93/5/599    most recent
expphysiol.2007.041830v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Pan, C.-H.
Right arrow Articles by Lin, C.-S.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pan, C.-H.
Right arrow Articles by Lin, C.-S.
Related Collections
Right arrow Heart/Cardiac Muscle

Interplay of angiotensin II and angiotensin(1–7) in the regulation of matrix metalloproteinases of human cardiocytes

Chun-Hsu Pan1, Cheng-Hao Wen1 and Chih-Sheng Lin1

1 Department of Biological Science and Technology, National Chiao Tung University, Hsinchu, Taiwan

Angiotensin II (Ang II) is a critical effector in the renin–angiotensin system (RAS), which modulates cardiovascular homeostasis, and the matrix metalloproteinases (MMPs) and tissue inhibitors of matrix metalloproteinases (TIMPs) related metabolism of extracellular matrix (ECM). Angiotensin(1–7) [Ang(1–7)] is another bioactive peptide in the RAS and is considered to have opposite effects to Ang II. However, the modulation of MMPs and TIMPs by Ang(1–7) is largely unclear in cardiocytes, and the antagonistic effects of Ang(1–7) on Ang II-mediated expression of MMPs and TIMPs have yet to be identified. In the present study, we examined the transcript expression of MMPs and TIMPs in human cardiac fibroblasts (HCF) and myocytes (HCM) after Ang II or Ang(1–7) stimulation, and analysed the antagonistic effects of Ang(1–7) to Ang II. The results show that Ang II decreased transcript expression of MMP-1, MMP-2, TIMP-1, TIMP-2 and TIMP-3, but upregulated MMP-9 expression in the HCF cells. Transcript expression of MMP-9 and TIMP-2 was downregulated by Ang(1–7) in the same cells. In the HCM cells, Ang II induced MMP-1 and MMP-9 overexpression but MMP-2 was downregulated. All of the examined MMPs and TIMPs, except MMP-9, were markedly decreased by Ang(1–7). In the studies of antagonistic effects of Ang(1–7) to Ang II, Ang(1–7) counteracted the effects of Ang II-mediated regulation on MMP-9 and TIMP-1 in the HCF cells compared with the control group. The regulations of all examined MMPs by Ang II were reversed to basal expression by Ang(1–7) in the HCM cells. Our results suggest that Ang(1–7) and Ang II have opposite and antagonistic effects on regulation of transcription of MMPs and TIMPs in primary cultures of human cardiocytes. These effects lead to increased ratios of MMPs to TIMPs after Ang II stimulation and decreased ratios of MMPs to TIMPs after Ang(1–7) stimulation; effects which may partly depend of the type of cardiac cells. These results suggest a potential role for Ang(1–7) in attenuatating cardiac damage in Ang II-induced ECM remodelling.

(Received 20 December 2007; accepted after revision 18 February 2008; first published online 22 February 2008)
Corresponding author: C.-S. Lin: Department of Biological Science and Technology, National Chiao Tung University, No. 75 Po-Ai Street, Hsinchu 30068, Taiwan. Email: lincs{at}mail.nctu.edu.tw




This article has been cited by other articles:


Home page
Exp PhysiolHome page
M. K. Raizada and J. F. R. Paton
Recent advances in the renin-angiotensin system: angiotensin-converting enzyme 2 and (pro)renin receptor
Exp Physiol, May 1, 2008; 93(5): 517 - 518.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the The Physiological Society.